This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Chong Kun Dang Pharmaceutical Corporation. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: SeoHee Lee: Innovator in CETP Inhibition
Introduction
SeoHee Lee is a prominent inventor based in Yongin, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit CETP activity. His innovative work aims to improve cholesterol levels in patients, showcasing his commitment to advancing medical science.
Latest Patents
SeoHee Lee holds a patent for "Cycloalkenyl aryl derivatives for CETP inhibitor." This invention relates to cycloalkenyl aryl derivatives, their isomers, pharmaceutically acceptable salts, hydrates, or solvates. The patent also includes a method for preparing these derivatives and pharmaceutical compositions containing them. The compounds developed by SeoHee Lee demonstrate the ability to increase HDL-cholesterol while decreasing LDL-cholesterol, which is crucial for cardiovascular health. He has 1 patent to his name.
Career Highlights
SeoHee Lee is currently employed at Chong Kun Dang Pharmaceutical Corporation, a leading pharmaceutical company in South Korea. His role involves research and development, where he focuses on creating innovative solutions for health-related issues. His work has positioned him as a key player in the pharmaceutical industry.
Collaborations
SeoHee Lee has collaborated with talented coworkers, including Suyeal Bae and Jung Taek Oh. Together, they contribute to the advancement of pharmaceutical research and development, fostering a collaborative environment that encourages innovation.
Conclusion
SeoHee Lee's contributions to the field of CETP inhibition highlight his dedication to improving health outcomes through innovative pharmaceutical solutions. His work continues to inspire advancements in medical research and development.